These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 6285736)
1. Mechanism of action and selectivity of acyclovir. Elion GB Am J Med; 1982 Jul; 73(1A):7-13. PubMed ID: 6285736 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function. Derse D; Cheng YC; Furman PA; St Clair MH; Elion GB J Biol Chem; 1981 Nov; 256(22):11447-51. PubMed ID: 6271750 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir. St Clair MH; Furman PA; Lubbers CM; Elion GB Antimicrob Agents Chemother; 1980 Nov; 18(5):741-5. PubMed ID: 7192534 [TBL] [Abstract][Full Text] [Related]
4. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346 [TBL] [Abstract][Full Text] [Related]
5. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells. Stenberg K; Larsson A; Datema R J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021 [TBL] [Abstract][Full Text] [Related]
6. The biochemistry and mechanism of action of acyclovir. Elion GB J Antimicrob Chemother; 1983 Sep; 12 Suppl B():9-17. PubMed ID: 6313600 [TBL] [Abstract][Full Text] [Related]
7. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses. Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922 [TBL] [Abstract][Full Text] [Related]
8. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG. Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486 [TBL] [Abstract][Full Text] [Related]
9. (+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses. Field AK; Tuomari AV; McGeever-Rubin B; Terry BJ; Mazina KE; Haffey ML; Hagen ME; Clark JM; Braitman A; Slusarchyk WA Antiviral Res; 1990 Jan; 13(1):41-52. PubMed ID: 2159261 [TBL] [Abstract][Full Text] [Related]
10. Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses. Pagano JS; Datta AK Am J Med; 1982 Jul; 73(1A):18-26. PubMed ID: 6285710 [TBL] [Abstract][Full Text] [Related]
11. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient. Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of acyclovir diphosphate by cellular enzymes. Miller WH; Miller RL Biochem Pharmacol; 1982 Dec; 31(23):3879-84. PubMed ID: 7159465 [TBL] [Abstract][Full Text] [Related]
13. Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci. Schnipper LE; Crumpacker CS Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2270-3. PubMed ID: 6246532 [TBL] [Abstract][Full Text] [Related]
14. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Darby G; Field HJ; Salisbury SA Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650 [TBL] [Abstract][Full Text] [Related]
15. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Elion GB; Furman PA; Fyfe JA; de Miranda P; Beauchamp L; Schaeffer HJ Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5716-20. PubMed ID: 202961 [TBL] [Abstract][Full Text] [Related]
16. Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Coen DM; Schaffer PA Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2265-9. PubMed ID: 6246531 [TBL] [Abstract][Full Text] [Related]
17. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells. Saijo M; Suzutani T; Yoshida I Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651 [TBL] [Abstract][Full Text] [Related]
18. Acyclovir inhibition of viral DNA chain elongation in herpes simplex virus-infected cells. McGuirt PV; Furman PA Am J Med; 1982 Jul; 73(1A):67-71. PubMed ID: 6285735 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the modes of antiviral action of 2'-nor-deoxyguanosine and its cyclic phosphate, 2'-nor-cyclic GMP. Germershausen J; Bostedor R; Liou R; Field AK; Wagner AF; MacCoss M; Tolman RL; Karkas JD Antimicrob Agents Chemother; 1986 Jun; 29(6):1025-31. PubMed ID: 3015013 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses. Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]